This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 696802. Horizon 2020 has a goal of ensuring that Europe produces world-class science, removes barriers to innovation and makes it easier for the public and private sectors to work together in delivering innovation.
P1vital Products Ltd is sponsoring this research and is the manufacturer of the P1vital® PReDicT Test medical device.
P1vital Ltd is managing the clinical study and specialise in experimental medicine studies for psychiatry and obesity.